Literature DB >> 22178587

Subcarinal node metastasis in thoracic esophageal squamous cell carcinoma.

Jingeng Liu1, Yi Hu, Xuan Xie, Jianhua Fu.   

Abstract

BACKGROUND: Subcarinal node metastasis is common in patients with esophageal cancer. Some scholars have suggested that subcarinal nodes might not need to be sampled or dissected in patients with superficial squamous cell carcinoma of the thoracic esophagus. This research investigated the frequency of subcarinal node metastasis in patients with esophageal squamous cell carcinoma, identified the factors correlated to subcarinal node metastasis, and evaluated the clinical relevance of subcarinal node metastasis in thoracic esophageal squamous cell carcinoma.
METHODS: We retrospectively analyzed the clinical data of 1,812 consecutive patients with thoracic esophageal squamous cell carcinoma who underwent esophagectomy in the Cancer Center of Sun Yat-sen University. The surgical procedures included the left transthoracic procedure, Ivor-Lewis approach, and the cervical-thoracoabdominal procedure.
RESULTS: The frequency of subcarinal node metastasis was 10.0%. The univariate and multivariate analysis showed that longer tumor length, higher pathologic T stage, lower histologic grade, and positive lymph node metastases of other groups were associated with a higher frequency of subcarinal node metastasis (all p<0.05). Patients with solitary subcarinal node metastasis had a significantly lower 5-year cumulative survival rate than those with solitary paraesophageal node metastasis (25.3% vs 39.6%, p<0.05).
CONCLUSIONS: Longer tumor length, higher pathologic T stage, lower histologic grade, and positive lymph node metastases of other groups are associated with a higher frequency of subcarinal node metastasis. Subcarinal node metastasis indicates worse prognosis of patients with thoracic esophageal squamous cell carcinoma compared with paraesophageal node metastasis.
Copyright © 2012 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22178587     DOI: 10.1016/j.athoracsur.2011.10.011

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  13 in total

1.  Mediastinoscopic esophagectomy for patients with early esophageal cancer.

Authors:  Qian-Yun Wang; Jing-Pei Li; Lei Zhang; Nan-Qing Jiang; Zhong-Lin Wang; Xiao-Ying Zhang
Journal:  J Thorac Dis       Date:  2015-07       Impact factor: 2.895

2.  Prognostic significance of SLC9A9 in patients with resectable esophageal squamous cell carcinoma.

Authors:  Junying Chen; Jing Wen; Yuzhen Zheng; Hong Yang; Kongjia Luo; Qianwen Liu; Ronggui Hu; Zihui Tan; Qingyuan Huang; Jianhua Fu
Journal:  Tumour Biol       Date:  2015-04-03

Review 3.  Chinese expert consensus on mediastinal lymph node dissection in esophagectomy for esophageal cancer (2017 edition).

Authors:  Hui Li; Wentao Fang; Zhentao Yu; Yousheng Mao; Longqi Chen; Jie He; Tiehua Rong; Chun Chen; Haiquan Chen; Keneng Chen; Ming Du; Yongtao Han; Jian Hu; Jianhua Fu; Xiaobin Hou; Taiqian Gong; Yin Li; Junfeng Liu; Shuoyan Liu; Lijie Tan; Hui Tian; Qun Wang; Jiaqing Xiang; Meiqing Xu; Xin Ye; Bin You; Renquan Zhang; Yan Zhao
Journal:  J Thorac Dis       Date:  2018-04       Impact factor: 2.895

4.  Adjuvant therapy for pathological T3N0M0 esophageal squamous cell carcinoma.

Authors:  Xiaobin Zhang; Yu Yang; Yifeng Sun; Bo Ye; Xufeng Guo; Teng Mao; Rong Hua; Bin Li; Haiyong Gu; Jun Liu; Zhigang Li
Journal:  J Thorac Dis       Date:  2019-06       Impact factor: 2.895

5.  Evaluation of subcarinal lymph node dissection and metastasis in transmediastinal radical esophagectomy.

Authors:  Jun Shibamoto; Hitoshi Fujiwara; Hirotaka Konishi; Atsushi Shiozaki; Takuma Ohashi; Takeshi Kubota; Hiroki Shimizu; Tomohiro Arita; Yusuke Yamamoto; Ryo Morimura; Yoshiaki Kuriu; Hisashi Ikoma; Kazuma Okamoto; Eigo Otsuji
Journal:  Esophagus       Date:  2021-02-18       Impact factor: 4.230

6.  The impact of body mass index on complication and survival in resected oesophageal cancer: a clinical-based cohort and meta-analysis.

Authors:  S S Zhang; H Yang; K J Luo; Q Y Huang; J Y Chen; F Yang; X L Cai; X Xie; Q W Liu; A E Bella; R G Hu; J Wen; Y Hu; J H Fu
Journal:  Br J Cancer       Date:  2013-11-07       Impact factor: 7.640

7.  Smoking affects treatment outcome in patients with resected esophageal squamous cell carcinoma who received chemotherapy.

Authors:  Yuzhen Zheng; Xun Cao; Jing Wen; Hong Yang; Kongjia Luo; Qianwen Liu; Qingyuan Huang; Junying Chen; Jianhua Fu
Journal:  PLoS One       Date:  2015-04-13       Impact factor: 3.240

8.  Prognostic value of pretreatment serum alanine aminotransferase/aspartate aminotransferase (ALT/AST) ratio and gamma glutamyltransferase (GGT) in patients with esophageal squamous cell carcinoma.

Authors:  Hao Huang; Xue-Ping Wang; Xiao-Hui Li; Hao Chen; Xin Zheng; Jian-Hua Lin; Ting Kang; Lin Zhang; Pei-Song Chen
Journal:  BMC Cancer       Date:  2017-08-14       Impact factor: 4.430

9.  Preoperative serum fibrinogen is an independent prognostic factor in operable esophageal cancer.

Authors:  Shui-Shen Zhang; Yi-Yan Lei; Xiao-Li Cai; Hong Yang; Xin Xia; Kong-Jia Luo; Chun-Hua Su; Jian-Yong Zou; Bo Zeng; Yi Hu; Hong-He Luo
Journal:  Oncotarget       Date:  2016-05-03

10.  Feasibility and strategy for left tracheobronchial lymph node dissection in thoracolaparoscopic esophageal cancer surgery.

Authors:  Jiangbo Lin; Mingqiang Kang; Shuchen Chen; Fan Deng; Zhiyang Han; Jihong Lin
Journal:  Thorac Cancer       Date:  2015-09-16       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.